Case Report


Severe hypoglycemia complicating hepatocellular carcinoma

,  ,  ,  ,  

1 Department of Endocrinology, Diabetology and Nutrition, Military Hospital Moulay Ismail, Meknes, Morocco

2 Faculty of Medicine and Pharmacy, University Sidi Mohamed Ben Abdellah, Fez, Morocco

3 Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco

Address correspondence to:

Sara Derrou

Department of Endocrinology, Diabetology and Nutrition, Military Hospital Moulay Ismail, Meknes,

Morocco

Message to Corresponding Author


Article ID: 101119Z01SD2020

doi: 10.5348/101119Z01SD2020CR

Access full text article on other devices

Access PDF of article on other devices

How to cite this article

Derrou S, Benabdelfedil Y, El Guendouz F, Ouleghzal H, Safi S. Severe hypoglycemia complicating hepatocellular carcinoma. Int J Case Rep Images 2020;11:101119Z01SD2020.

ABSTRACT


Introduction: Paraneoplastic or ectopic endocrine syndromes are the consequence of aberrant hormonal production or of substances with hormonal effect, by a neoplastic tissue originally devoid of this endocrine activity. In this sense, hypoglycemia by extra-pancreatic tumors “non-islet cell tumor hypoglycemia” especially of hepatic origin is often severe and iterative.

Case Report: We report the clinical case of a 56-year-old patient, type 2 diabetic for 10 years, diagnosed with hepatocellular carcinoma with the onset of severe hypoglycemia attacks, persistent even after stopping treatment. The first-line assessment in search of renal failure, adrenal insufficiency, and hypothyroidism returned without abnormality. However, glycemic monitoring showed venous hypoglycemia at 0.38 g/L with concomitant insulinemia and low peptide C. Considering the clinical context, the insulin-like growth factor-1 (IGF1) was low. IGF2 was within normal limits. Given the inextricable and incurable nature of the tumor, dietary measures were required in our patient for stabilization of the blood sugar.

Conclusion: Hypoglycemia induced by tumor secretion of IGF2 is a rare paraneoplastic syndrome. It should be considered with tumor syndrome and organic hypoglycemia. Management remains poorly defined.

Keywords: Hepatocellular carcinoma, Insulin-like growth factor-2, Paraneoplastic syndrome, Severe hypoglycemia

SUPPORTING INFORMATION


Author Contributions

Sara Derrou - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published

Yousra Benabdelfedil - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published

Fayçal El Guendouz - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published

Hassane Ouleghzal - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published

Somaya Safi - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published

Source of Support

None

Consent Statement

Written informed consent was obtained from the patient for publication of this article.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Conflict of Interest

Authors declare no conflict of interest.

Copyright

© 2020 Sara Derrou et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.